工程采用细胞疗法用于固体瘤
Maryam Sanjary1, Ameneh Shokati2, Mahshid Akhavan Rahnama3
1Department of Clinical Biochemistry, Faculty of Medical Science, Tarbiat Modares University, Tehran, Iran.
Medical oncology (Northwood, London, England)
|September 27, 2025
概括
适应性细胞疗法 (ACT) 对固体瘤有希望,克服了免疫抑制和抗原逃逸等挑战. 工程T细胞 (CAR-T,TCR-T,TILs) 使用CRISPR/Cas9等工具提高了个性化癌症治疗的疗效.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 适应性细胞疗法 (ACT) 在血液癌症中表现出成功,但在固体瘤中面临障碍.
- 挑战包括免疫细胞透不良,多种瘤抗原和抑制性瘤微环境.
研究的目的:
- 审查当前提高ACT在固体瘤中的疗效的策略.
- 探索工程T细胞和基因编辑技术的进步.
主要方法:
- 专注于工程T细胞:CAR-T,TCR-T和瘤透淋巴细胞 (TIL).
- 讨论瘤向,克服免疫抑制和抗原逃逸的策略.
- 突出了基因编辑工具,如CRISPR/Cas9用于下一代免疫细胞.
主要成果:
- 工程T细胞证明了改善固体瘤治疗的潜力.
- 克里斯普尔/Cas9促进了更具功能和更安全的免疫细胞的发展.
- 工程和系统生物学的整合提高了ACT的能力.
结论:
- ACT策略正在发展,以解决固体瘤的复杂性.
- 下一代ACT对个性化癌症治疗具有重大前景.
- 结合新技术的进一步研究对于临床翻译至关重要.
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Adaptive Mechanisms in Cancer Cells
7.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
7.0K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K


